W ELLIOTT

3.7k total citations · 1 hit paper
60 papers, 2.8k citations indexed

About

W ELLIOTT is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, W ELLIOTT has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in W ELLIOTT's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Metabolism and Genetic Disorders (7 papers). W ELLIOTT is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Metabolism and Genetic Disorders (7 papers). W ELLIOTT collaborates with scholars based in United States and Canada. W ELLIOTT's co-authors include Richard Gorlin, Lawrence S. Cohen, Michael D. Klein, Ernest L. Fallen, William M. Bennett, Ellis L. Rolett, Donald C. Houghton, M IZHAR, Jay Garg and Henry R. Black and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Investigation.

In The Last Decade

W ELLIOTT

60 papers receiving 2.5k citations

Hit Papers

Coronary heart disease 1966 2026 1986 2006 1966 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W ELLIOTT United States 24 1.5k 696 483 248 229 60 2.8k
Lars Werkö Sweden 34 1.7k 1.2× 359 0.5× 548 1.1× 248 1.0× 336 1.5× 164 3.6k
Terrence J. Montague Canada 29 1.9k 1.3× 402 0.6× 336 0.7× 186 0.8× 270 1.2× 105 2.8k
Michael J. Shea United States 24 1.5k 1.0× 726 1.0× 485 1.0× 374 1.5× 48 0.2× 95 3.0k
Markku Mähönen Finland 28 2.1k 1.4× 409 0.6× 568 1.2× 238 1.0× 686 3.0× 51 4.5k
E. Harvey Estes United States 33 2.5k 1.7× 566 0.8× 761 1.6× 486 2.0× 443 1.9× 102 4.9k
Christopher M Florkowski New Zealand 23 725 0.5× 394 0.6× 415 0.9× 607 2.4× 254 1.1× 93 2.8k
William B. Hood United States 40 3.8k 2.6× 1.4k 2.0× 880 1.8× 554 2.2× 208 0.9× 149 5.6k
Joan M. Fair United States 22 1.6k 1.1× 333 0.5× 853 1.8× 166 0.7× 701 3.1× 36 3.7k
Raymond K. Neff United States 16 899 0.6× 246 0.4× 1.2k 2.4× 126 0.5× 187 0.8× 25 3.4k
Javier Muñiz Spain 33 2.3k 1.6× 338 0.5× 1.0k 2.2× 396 1.6× 279 1.2× 244 4.3k

Countries citing papers authored by W ELLIOTT

Since Specialization
Citations

This map shows the geographic impact of W ELLIOTT's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W ELLIOTT with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W ELLIOTT more than expected).

Fields of papers citing papers by W ELLIOTT

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W ELLIOTT. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W ELLIOTT. The network helps show where W ELLIOTT may publish in the future.

Co-authorship network of co-authors of W ELLIOTT

This figure shows the co-authorship network connecting the top 25 collaborators of W ELLIOTT. A scholar is included among the top collaborators of W ELLIOTT based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W ELLIOTT. W ELLIOTT is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Jay, et al.. (2005). Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts. American Journal of Hypertension. 18(5). 619–626. 189 indexed citations
2.
Gürbüz, Ahmet Tayfun, et al.. (2004). Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. European Journal of Cardio-Thoracic Surgery. 27(1). 138–149. 17 indexed citations
3.
Allen, Lee F., et al.. (2002). Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer. Seminars in Oncology. 29(3). 11–21. 83 indexed citations
4.
ELLIOTT, W. (1999). Detection, treatment, and control of adult hypertension in Northwest Indiana. American Journal of Hypertension. 12(8). 830–834. 6 indexed citations
5.
ELLIOTT, W. (1999). Circadian variation in blood pressureImplications for the elderly patient. American Journal of Hypertension. 12(2). 43S–49S. 42 indexed citations
6.
ELLIOTT, W, et al.. (1990). The Role of Ischemia in Acquired Cystic Kidney Disease. American Journal of Kidney Diseases. 15(1). 55–60. 21 indexed citations
7.
Glass, Allan R., James M. Cerletty, W ELLIOTT, et al.. (1990). Ketoconazole reduces elevated serum levels of 1,25-dihydroxy vitamin D in hypercalcemic sarcoidosis. Journal of Endocrinological Investigation. 13(5). 407–413. 21 indexed citations
8.
ELLIOTT, W, et al.. (1985). Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes.. Journal of Pharmacology and Experimental Therapeutics. 233(1). 264–270. 23 indexed citations
9.
ELLIOTT, W, et al.. (1983). cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.. PubMed. 43(8). 3759–62. 10 indexed citations
10.
Bennett, William M., W ELLIOTT, David N. Gilbert, & Donald C. Houghton. (1982). Effect of netilmicin (N) pretreatment on renal cortical gentamicin (G) concentration and G nephrotoxicity. Kidney International. 21(1). 1 indexed citations
11.
ELLIOTT, W, et al.. (1982). Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity.. PubMed. 100(4). 501–12. 46 indexed citations
12.
ELLIOTT, W, Richard Parker, Donald C. Houghton, David N. Gilbert, & William M. Bennett. (1982). Comparative Nephrotoxicity of Dibekacin and Gentamicin in Rats. The Journal of Urology. 127(2). 394–394. 4 indexed citations
13.
ELLIOTT, W, R K Lynn, Donald C. Houghton, John M. Kennish, & William M. Bennett. (1982). Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites. Toxicology and Applied Pharmacology. 62(1). 179–182. 20 indexed citations
14.
Parker, Richard, John M. Barry, W ELLIOTT, et al.. (1980). Percutaneous aspiration biopsy of renal allografts using ultrasound localization. Urology. 15(5). 534–535. 8 indexed citations
15.
McCarron, David A., W ELLIOTT, Jeffrey S. Rose, & William M. Bennett. (1979). Severe mixed metabolic acidosis secondary to rhabdomyolysis. The American Journal of Medicine. 67(5). 905–908. 21 indexed citations
16.
McHenry, Paul L., et al.. (1970). False positive ECG response to exercise secondary to hyperventilation: Cineangiographic correlation. American Heart Journal. 79(5). 683–687. 38 indexed citations
17.
Sullivan, Jay M., Warren J. Taylor, W ELLIOTT, & Richard Gorlin. (1967). Regional Myocardial Blood Flow*. Journal of Clinical Investigation. 46(9). 1402–1412. 53 indexed citations
18.
ELLIOTT, W, et al.. (1967). The anginal syndrome with normal coronary arteriography.. PubMed. 80. 59–70. 151 indexed citations
19.
Cohen, Lawrence S., W ELLIOTT, Michael D. Klein, & Richard Gorlin. (1966). Coronary heart disease. The American Journal of Cardiology. 17(2). 153–168. 904 indexed citations breakdown →
20.
Gorlin, Richard, Ellis L. Rolett, Peter M. Yurchak, & W ELLIOTT. (1964). Left Ventricular Volume in Man Measured by Thermodilution*. Journal of Clinical Investigation. 43(6). 1203–1221. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026